This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Alivus Life Sciences Limited. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: The Innovative Journey of Shrikant Prabhakar Keshav
Introduction
Shrikant Prabhakar Keshav, based in Panvel, India, is an accomplished inventor known for his significant contributions to the pharmaceutical sector. With a focus on developing processes for drug preparation, Keshav has made strides in the field of medicinal chemistry, particularly with his patented work involving brivaracetam.
Latest Patents
Keshav holds a patent for a process for the preparation of brivaracetam. This invention outlines methods related to brivaracetam, a compound that has valuable therapeutic applications. The patent also encompasses the preparation and conversion of other related compounds, showcasing Keshav's expertise in the synthesis of complex pharmaceutical substances.
Career Highlights
Currently, Shrikant Prabhakar Keshav is affiliated with Alivus Life Sciences Limited, where he engages in research and development activities aimed at advancing innovative pharmaceutical solutions. His dedication to enhancing drug formulation processes reflects his commitment to improving healthcare outcomes.
Collaborations
Collaborating with notable industry professionals such as Sandip Tukaram Gadge and Nandkumar Gaikwad, Keshav is part of a dynamic team that fosters creativity and innovation within their projects. These collaborations further substantiate his influence and contribution to the field of pharmaceutical sciences.
Conclusion
Shrikant Prabhakar Keshav's efforts in the field of drug preparation exemplify the spirit of innovation and technical prowess. With a keen understanding of medicinal compounds and a successful patent to his name, Keshav continues to impact the pharmaceutical industry positively, driving forward advancements in medicine through his expertise and collaborative work.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile